Evidence map›Paper›PMID 36110343›Full record

ArticleHealth science reports2022

Understanding the use of oral rehydration therapy: A narrative review from clinical practice to main recommendations.

Ziba Aghsaeifard, Ghobad Heidari, Reza Alizadeh

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Efficacy and safety ofFrontiers in cellular and infection microbiology · 2025
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Frontiers in pediatrics · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Ziba AghsaeifardDepartment of Internal Medicine, Sina Hospital Tehran University of Medical Sciences Tehran Iran.ORCID 0000-0001-5095-1654
Ghobad HeidariDepartment of Pediatrics Lorestan University of Medical Sciences Khorramabad Iran.ORCID 0000-0001-9597-2117
Reza AlizadehDepartment of Anesthesiology and Intensive Care, Faculty of Medicine AJA University of Medical Sciences Tehran Iran.ORCID 0000-0003-3469-0735
Aja University of Medical Sciences · IRLorestan University of Medical Sciences · IRSina Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Fluid loss due to diarrhea remains a significant cause of mortality among children under the age of 5. Methods: Oral rehydration therapy (ORT) is a first-line therapeutic measure to compensate the volume loss due to diarrhea and vomiting among gastroenteritis patients. Despite adequate knowledge, the practice of ORT is limited, particularly in developing countries. Results: Several recommendations are provided regarding the use of ORT to treat hypovolemia, however, the information regarding its adequate usage is restricted within the healthcare centers and professionals. Conclusion: This review highlights the importance of providing recommendations regarding the use of ORT. We also discuss the barriers and alternatives that might limit its use.

Indexed as

childrendiarrheafluid lossgastroenteritishypovolemiaoral rehydration therapy (ORT)

Identifiers

PMID36110343
PMCPMC9464461
OpenAlexW4295151990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.